Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Peripheral Arterial Disease: Features

Case Report
Identifying and Repairing Dissections Using Intravascular Ultrasound: Are We There Yet?
08/19/2019
The authors present a case that illustrates the importance of IVUS in characterizing dissections and brings forward the question of whether IVUS should be used as the primary modality to identify and repair dissections.
The authors present a case that illustrates the importance of IVUS in characterizing dissections and brings forward the question of whether IVUS should be used as the primary modality to identify and repair dissections.
The authors present a case that...
08/19/2019
Vascular Disease Management
Case Report
The No-Reflow Phenomenon in Below-the-Knee Vessels After Percutaneous Revascularization of the Superficial Femoral Artery
08/19/2019
Alhazmi and colleagues describe a patient presenting with diminished distal flow in all 3 below-the-knee vessels, despite successful recanalization and patency of the upstream SFA, and absence of significant residual stenosis.
Alhazmi and colleagues describe a patient presenting with diminished distal flow in all 3 below-the-knee vessels, despite successful recanalization and patency of the upstream SFA, and absence of significant residual stenosis.
Alhazmi and colleagues describe...
08/19/2019
Vascular Disease Management
Videos
MicroStent Is Significant Step in Improving Treatment of CLI Patients
08/14/2019
Robert Beasley, MD, and Mahmood Razavi, MD, discuss the challenges of treating below-the-knee disease and how the MicroStent by Micromedical can help to improve outcomes. For more information on STAND or the MicroStent...
Robert Beasley, MD, and Mahmood Razavi, MD, discuss the challenges of treating below-the-knee disease and how the MicroStent by Micromedical can help to improve outcomes. For more information on STAND or the MicroStent...
Robert Beasley, MD, and Mahmood...
08/14/2019
Vascular Disease Management
Videos
Update From the IN.PACT Deep Trial and Lessons Learned
08/14/2019
Thomas Zeller, MD, reported on 5-year follow-up data for the use of a drug-coated balloon (DCB) below the knee in the IN.PACT DEEP trial.
Thomas Zeller, MD, reported on 5-year follow-up data for the use of a drug-coated balloon (DCB) below the knee in the IN.PACT DEEP trial.
Thomas Zeller, MD, reported on...
08/14/2019
Vascular Disease Management
Case Report
Pedal Revascularization: Extending the Limits of Endovascular or Surgical Means to Prevent Amputation
06/29/2019
I this case, rather than opting for amputation in a patient with CLI not amenable to open bypass surgery or endovascular therapy, a novel open surgical approach was used to revascularize the pedal arteries.
I this case, rather than opting for amputation in a patient with CLI not amenable to open bypass surgery or endovascular therapy, a novel open surgical approach was used to revascularize the pedal arteries.
I this case, rather than opting...
06/29/2019
Vascular Disease Management
Case Report
Exotic Access for a Bilateral Above-Knee Amputee With Critical Limb Ischemia
06/14/2019
In the case herein, procedural success — defined by stenosis reduction and distal reperfusion of bilateral stumps — was dependent upon gaining arterial access through exotic techniques and crossing the CTOs.
In the case herein, procedural success — defined by stenosis reduction and distal reperfusion of bilateral stumps — was dependent upon gaining arterial access through exotic techniques and crossing the CTOs.
In the case herein, procedural...
06/14/2019
Vascular Disease Management
Case Report
Focusing on Amputation Prevention in a Challenging PAD Anatomical Subset
05/21/2019
The authors present a technique by gaining direct needle access retrograde into the proximal SFA occlusion using extravascular ultrasound with the goal of both increasing the probability of success and shortening procedural time.
The authors present a technique by gaining direct needle access retrograde into the proximal SFA occlusion using extravascular ultrasound with the goal of both increasing the probability of success and shortening procedural time.
The authors present a technique...
05/21/2019
Vascular Disease Management
Editor's Corner
The Merits of Supervised Exercise in Critical Limb Ischemia
05/21/2019
Dr Walker comments on an article by Fahad Younas, MD, and R. Kevin Rogers, MD, on “Supervised Exercise in Critical Limb Ischemia.”
Dr Walker comments on an article by Fahad Younas, MD, and R. Kevin Rogers, MD, on “Supervised Exercise in Critical Limb Ischemia.”
Dr Walker comments on an article...
05/21/2019
Vascular Disease Management
Case Report
The Nature of Dissections in Infrapopliteal Arteries: Insights from Intravascular Ultrasound Imaging
04/18/2019
Shammas and colleagues discuss how treatment of infrapopliteal arteries can be challenging due to the presence of medial calcinosis and fibrotic rings.
Shammas and colleagues discuss how treatment of infrapopliteal arteries can be challenging due to the presence of medial calcinosis and fibrotic rings.
Shammas and colleagues discuss...
04/18/2019
Vascular Disease Management
Original Research
Single Access Versus Dual Antegrade and Retrograde Access Approach for Chronic Total Occlusion Recanalization in Complex Peripheral Arterial Disease
02/22/2019
In this study, researchers evaluated the efficacy and safety of initial dual antegrade and retrograde access approach compared with single antegrade or retrograde approach for crossing any level of CTO.
In this study, researchers evaluated the efficacy and safety of initial dual antegrade and retrograde access approach compared with single antegrade or retrograde approach for crossing any level of CTO.
In this study, researchers...
02/22/2019
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement